HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michel Lagarde Selected Research

1- acetyl- 2- docosahexaenoyl- glycerophosphocholine

8/2017Docosahexaenoic acid-containing choline phospholipid modulates LPS-induced neuroinflammation in vivo and in microglia in vitro.
1/2016Efficient Docosahexaenoic Acid Uptake by the Brain from a Structured Phospholipid.
5/2011Brain-targeting form of docosahexaenoic acid for experimental stroke treatment: MRI evaluation and anti-oxidant impact.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michel Lagarde Research Topics

Disease

7Atherosclerosis
11/2018 - 03/2009
6Inflammation (Inflammations)
12/2020 - 04/2003
5Neurodegenerative Diseases (Neurodegenerative Disease)
03/2020 - 11/2016
5Diabetic Nephropathies (Diabetic Nephropathy)
07/2006 - 08/2004
4Ischemic Stroke
01/2020 - 01/2016
4Thrombosis (Thrombus)
11/2018 - 04/2009
4Cardiovascular Diseases (Cardiovascular Disease)
02/2013 - 08/2008
3Stroke (Strokes)
02/2019 - 05/2011
3Insulin Resistance
01/2018 - 05/2011
3Type 2 Diabetes Mellitus (MODY)
03/2009 - 08/2005
3Hyperglycemia
05/2007 - 09/2003
2Cystic Fibrosis (Mucoviscidosis)
12/2016 - 09/2007
2Obesity
02/2013 - 02/2008
2Necrosis
10/2010 - 04/2007
2Hypertrophy
07/2006 - 06/2005
2Diabetic Retinopathy (Retinopathy, Diabetic)
01/2005 - 07/2002
1Neuroinflammatory Diseases
08/2017
1Alzheimer Disease (Alzheimer's Disease)
12/2016
1Disease Progression
12/2016
1Non-alcoholic Fatty Liver Disease
11/2016
1Coronary Disease (Coronary Heart Disease)
04/2015
1Confusion (Bewilderment)
04/2014
1Abetalipoproteinemia (Bassen Kornzweig Syndrome)
07/2013
1Hypobetalipoproteinemias (Hypobetalipoproteinemia)
07/2013
1Metabolic Diseases (Metabolic Disease)
07/2013
1Cognitive Dysfunction
02/2013
1Neoplasms (Cancer)
07/2012
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
05/2011
1Barth Syndrome
09/2007
1Weight Loss (Weight Reduction)
09/2007
1Malaria
07/2006
1Hypertriglyceridemia
07/2005
1Pancreatitis
07/2005
1Dyslipidemias (Dyslipidemia)
07/2005

Drug/Important Bio-Agent (IBA)

8Docosahexaenoic AcidsIBA
03/2020 - 09/2007
6Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2018 - 09/2007
6oxidized low density lipoproteinIBA
07/2015 - 03/2009
4AntioxidantsIBA
12/2016 - 02/2010
4LipidsIBA
04/2015 - 08/2005
3Glutathione (Reduced Glutathione)IBA
01/2018 - 09/2007
3Phospholipids (Phosphatides)FDA LinkGeneric
08/2017 - 03/2009
31- acetyl- 2- docosahexaenoyl- glycerophosphocholineIBA
08/2017 - 05/2011
3LDL Lipoproteins (beta Lipoproteins)IBA
07/2015 - 05/2007
3Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
04/2015 - 04/2003
2Reactive Oxygen Species (Oxygen Radicals)IBA
12/2020 - 01/2014
2Eicosapentaenoic AcidIBA
11/2018 - 01/2016
2Phosphatidylcholines (Phosphatidylcholine)IBA
01/2017 - 01/2016
2ApolipoproteinsIBA
12/2016 - 07/2013
2CholesterolIBA
11/2016 - 07/2015
2HDL LipoproteinsIBA
07/2013 - 03/2009
2Lipoproteins (Lipoprotein)IBA
07/2013 - 07/2006
2Fatty Acids (Saturated Fatty Acids)IBA
02/2013 - 09/2007
2Triglycerides (Triacylglycerol)IBA
02/2013 - 07/2006
2Proteins (Proteins, Gene)FDA Link
05/2012 - 06/2005
2Insulin (Novolin)FDA Link
05/2012 - 05/2011
2Arachidonic Acid (Vitamin F)IBA
04/2009 - 09/2007
2p38 Mitogen-Activated Protein KinasesIBA
05/2007 - 09/2003
2Glucosamine (Dona)IBA
07/2006 - 06/2005
2Advanced Glycation End ProductsIBA
01/2005 - 08/2004
2Retinaldehyde (Retinal)IBA
01/2005 - 07/2002
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
12/2020
1Glycerophospholipids (Phosphoglycerides)IBA
01/2020
1Neuroprotective AgentsIBA
02/2019
14-hydroxy-2-hexenalIBA
01/2018
1Glucose (Dextrose)FDA LinkGeneric
01/2018
1Choline (Choline Chloride)IBA
08/2017
1Palmitic Acid (Hexadecanoic Acid)IBA
08/2017
1LipopolysaccharidesIBA
08/2017
1Vitamin EFDA LinkGeneric
12/2016
1Apolipoproteins E (ApoE)IBA
12/2016
1docosahexaenoyl lysophosphatidylcholineIBA
01/2016
1IsoprostanesIBA
04/2015
1AcidsIBA
04/2015
1protectin D1IBA
04/2014
110,17- dihydroxydocosa- 4,7,11,13,15,19- hexaenoic acidIBA
04/2014
1NADPH Oxidases (NAD(P)H oxidase)IBA
01/2014
1Peroxidase (Myeloperoxidase)IBA
01/2014
1geduninIBA
07/2012
1LimoninsIBA
07/2012
1Oxidants (Oxidizing Agents)IBA
05/2012
14-hydroxy-2-nonenal (4-hydroxynonenal)IBA
05/2012
1Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
05/2011
1Caspase 3 (Caspase-3)IBA
10/2010
1VLDL LipoproteinsIBA
03/2009
1CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferaseIBA
09/2007
1EnzymesIBA
09/2007
1phosphatidylglycerophosphateIBA
09/2007
1Cardiolipins (Cardiolipin)IBA
09/2007
1PhosphatidylglycerolsIBA
09/2007
1MitogensIBA
04/2007
1Bee Venoms (Bee Venom)IBA
07/2006
1Phospholipases (Phospholipase)IBA
07/2006
1Secretory Phospholipases A2IBA
07/2006
1Lipoprotein Lipase (Diacylglycerol Lipase)IBA
07/2005
1Immunoglobulin G (IgG)IBA
07/2005
1AutoantibodiesIBA
07/2005
1Cyclin-Dependent Kinase Inhibitor p21IBA
06/2005
1GangliosidesIBA
06/2005

Therapy/Procedure

5Therapeutics
03/2020 - 11/2016
2Intravenous Injections
01/2018 - 05/2011